The pharmaceutical industry is in a state of flux and with many drugs going off-patent in 2015 affecting drugmakers’ billions of sales. With this change, manufacturers have to look at ways to reduce costs and improve profit margins whilst promising safety and efficacy of their medicines.
Health Economics Global Congress 2015 Europe provides a unique platform for business knowledge sharing and convergence of top tier government, hospitals, pharmaceuticals, biotechnology, non-profit organisations, as well as regional and local manufacturers to discuss and share on the macroeconomic factors, policies, issues and drivers that will steer pharmaceutical industry.